FDA — authorised 18 November 1999
- Application: BLA020744
- Marketing authorisation holder: CHIESI USA INC
- Status: supplemented
FDA authorised Curosurf on 18 November 1999
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 18 November 1999; FDA has authorised it.
CHIESI USA INC holds the US marketing authorisation.